Embecta Corp. (EMBC) Earnings Call Analysis

NASDAQ · Healthcare · Medical Instruments & Supplies

12/25

Growth 0 Margin 1 Expansion 5 Platform 2 Financial 4

latest quarter score

Earnings Reports

12
Embecta (EMBC) Q3 2026: International Up 11.5% as Auto-Injector Platform Expands TAM
August 07, 2026
10
Embecta (EMBC) Q2 2026: U.S. Pen Needle Revenue Falls $53M, Forcing Guidance Reset and Portfolio Shift
June 16, 2026
16
Embecta (EMBC) Q3 2025: U.S. Revenue Jumps 12% as Brand Transition and Debt Paydown Accelerate
June 16, 2026
11
MBECTA (EMBC) Q4 2025: Gross Margin Slides 210bps on Cannula Cost Spike, Growth Bets Shift to GLP-1
June 16, 2026
11
EMBC Q1 2026: International Revenue Up 4.6% as U.S. Pricing Headwinds Shift Full-Year Guide Lower
June 15, 2026
14
Embecta (EMBC) Q2 2025: $7M Cost Takeout Offsets 9.8% Revenue Drop Amid Pharmacy Disruption
July 06, 2025

Browse all companies